The global joint replacement devices market is expected to reach 31.09 billion by 2030 from USD 23.42 billion in 2024, at a CAGR of 4.8% from 2024 to 2030. Technological advancements such as use of 3D printing with the manufacturing process, introduction of smart implants, and increased access to latest and innovative implants supports the growth of joint replacement devices market. Further, rising number of sport injuries and increased incidence of accidents that may result in fractures damage to the joints has resulted in rising demand for the joint replacement devices.
“The knee replacement devices segment of product segment held the largest share of the market in 2023”
The joint replacement devices market is segmented based on product into knee replacement devices, hip replacement devices, shoulder replacement devices, elbow replacement devices, ankle replacement devices, wrist replacement devices, other replacement devices, and bone graft substitutes. The knee replacement devices accounted for a the highest share in 2023. Launch of smart knee replacement devices, rise in number of obese population, and increasing awareness initiatives is anticipated to fuel the growth of the segment. Developments knee replacement procedures with an assistance of robotic platform improves patient outcome significtly and is one of the important factors propelling the segment. For instance, the Mako Total Knee Replacement from Stryker Corporation (US) may result in less discomfort and a reduced recovery period as compared to traditional surgery.
“The total replacement segment of surgery type segment held the largest share of the market in 2023”
The joint replacement devices market can be segmented based on surgery type into total replacement, partial replacement, and revision replacement. Growing number for joint replacement surgeries such as knee and hip replacement surgeries and the unique properties of newly launched implants such as longevity and resistance to corrosion drives the segment growth. Increasing funding opportunities and advancements in robotic surgery drives the segment growth. Furthermore, the new and innovative implants assist with reduction in pain, fewer follow ups, reduced revisions, etc. that ultimately supports the growth of the market.
“The ambulatory care centers and trauma units segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The joint replacement devices market is segmented by end-users into hospitals & surgical centers, ambulatory care centers & trauma units, and orthopedic clinics. The ambulatory care centers and trauma units are expected to witness a significant growth during the forecast period. According to Definitive Healthcare there has been a 304% rise in knee replacement surgical procedures performed in ambulatory surgery centers during the period of 2018-2022. Increased accessibility and cost effectiveness at ambulatory care centers anticipated to propel the segment growth. Furthermore, rising preference for minimally invasive surgical techniques is expected to support the growth of this segment.
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in joint replacement devices market. Increasing number of investments, improved healthcare infrastructure and increasing investments in the emerging countries, majorly supports the demand for joint replacement devices. Furthermore, market leaders taking remarkable efforts to strengthen their reach in the Asia Pacific market to meet the growing demand for joint replacement devices. According to International Osteoporosis Foundation, more than 50% of osteoporotic hip fractures are expected to occur by 2050.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: Director-level–10%, C-level–14%, and Others–76%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and Middle East & Africa - 2%
The prominent players in the joint replacement devices market are as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany), Arthrex, Inc.(US), Enovis (US), Globus Medical, Inc. (US), Acumed LLC (US), Orthofix Medical Inc.(US) , MicroPort Scientiifc Corporation (China), CONMED Corporation (US), Medacta International (Switzerland), Paragon 28, Inc. (US) and, Meril Life Sciences Pvt. Ltd. (India).
The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments, and key market strategies.
Research Coverage
This report studies the joint replacement devices market based on product, surgery type, type, technique, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall joint replacement devices market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
• Analysis of key drivers (increasing demand for minimally invasive orthopaedic surgical procedures and rising number of sports injuries, increasing prevalence of orthopaedic diseases and disorders, and increasing research funding and initiatives adopted by orthopaedic manufacturers to promoted brand awareness, increasing adoption of sensor-based implants), restraints (risk and complications associated with orthopaedic surgical procedures, high costs associated with orthopaedic treatments, reduced reimbursements for orthopedic surgical procedures), opportunities (rising number of hospitals and shift towards outpatient care, advancement in robotic assisted orthopaedic surgeries and 3D printing), and challenges (dearth of skilled orthopaedic surgeons) influencing the growth of the joint replacement devices market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the joint replacement devices market
• Market Development: Comprehensive information about lucrative markets–the report analyses the joint replacement devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the joint replacement devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).
圖表清單 List of Tables & Figures
TABLE 1 JOINT REPLACEMENT DEVICES MARKET: INCLUSIONS & EXCLUSIONS 32
TABLE 2 JOINT REPLACEMENT DEVICES MARKET: PARAMETRIC ASSUMPTIONS 44
TABLE 3 JOINT REPLACEMENT DEVICES MARKET: RISK ASSESSMENT 45
TABLE 4 JOINT REPLACEMENT DEVICES MARKET: GRANTS AND FUNDING 59
TABLE 5 DIFFERENCES IN INFLATION-ADJUSTED MEDICARE REIMBURSEMENT 60
TABLE 6 JOINT REPLACEMENT DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 67
TABLE 7 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 8 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 9 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 10 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 11 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION 70
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 70
TABLE 14 US: CLASSIFICATION OF JOINT REPLACEMENT DEVICES 71
TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72
TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL
AND MEDICAL DEVICE AGENCY (PMDA) 76
TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 77
TABLE 18 REGULATORY APPROVALS FOR JOINT REPLACEMENT DEVICES, BY COUNTRY 79
TABLE 19 US: MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC IMPLANTATION SERVICES, 2023 (DRG CODES) 80
TABLE 20 US: MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC IMPLANTATION SERVICES, 2023 (CPT CODES) 81
TABLE 21 CANADA: MPS BILLING CODES, 2023 81
TABLE 22 GERMANY: OPS CODES, 2023 82
TABLE 23 UK: OPCS CODES, 2023 82
TABLE 24 AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES,
BY KEY PLAYER, 2023 (USD) 85
TABLE 25 AVERAGE SELLING PRICE TREND OF JOINT REPLACEMENT DEVICES,
BY REGION, 2021–2023 (USD) 86
TABLE 26 IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND) 87
TABLE 27 EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND) 88
TABLE 28 LIST OF MAJOR PATENT INNOVATIONS AND REGISTRATIONS,
JANUARY 2014–SEPTEMBER 2024 90
TABLE 29 JOINT REPLACEMENT DEVICES MARKET: PORTER’S FIVE FORCES 91
TABLE 30 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 93
TABLE 31 KEY BUYING CRITERIA, BY END USER 94
TABLE 32 JOINT REPLACEMENT DEVICES MARKET: KEY CONFERENCES
AND EVENTS, 2024–2025 95
TABLE 33 JOINT REPLACEMENT DEVICES MARKET: CURRENT UNMET NEEDS 100
TABLE 34 JOINT REPLACEMENT DEVICES MARKET: INTENSITY OF CURRENT UNMET NEEDS 100
TABLE 35 JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 104
TABLE 36 JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 105
TABLE 37 JOINT REPLACEMENT PROCEDURES DATA, (2023 VS 2030) 105
TABLE 38 KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 106
TABLE 39 KNEE REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 106
TABLE 40 TOTAL KNEE REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 107
TABLE 41 PARTIAL KNEE REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 108
TABLE 42 REVISION KNEE REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 108
TABLE 43 HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 109
TABLE 44 HIP REPLACEMENT DEVICES, BY REGION, 2022–2030 (USD MILLION) 110
TABLE 45 TOTAL HIP REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 111
TABLE 46 PARTIAL HIP REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 112
TABLE 47 REVISION HIP REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 112
TABLE 48 HIP RESURFACING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 113
TABLE 49 SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 114
TABLE 50 SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 114
TABLE 51 TOTAL SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 115
TABLE 52 PARTIAL SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 116
TABLE 53 REVERSE SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 117
TABLE 54 ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 117
TABLE 55 ANKLE REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 118
TABLE 56 TOTAL ANKLE REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 119
TABLE 57 ANKLE FUSION/FIXATION DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 119
TABLE 58 ELBOW REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 120
TABLE 59 WRIST REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 121
TABLE 60 OTHER JOINT REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 121
TABLE 61 BONE GRAFT SUBSTITUTES MARKET, BY REGION, 2022–2030 (USD MILLION) 122
TABLE 62 JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,
2022–2030 (USD MILLION) 124
TABLE 63 JOINT REPLACEMENT DEVICES MARKET FOR TOTAL REPLACEMENT PROCEDURES, BY REGION, 2022–2030 (USD MILLION) 125
TABLE 64 JOINT REPLACEMENT DEVICES MARKET FOR PARTIAL REPLACEMENT PROCEDURES, BY REGION, 2022–2030 (USD MILLION) 126
TABLE 65 JOINT REPLACEMENT DEVICES MARKET FOR REVISION REPLACEMENT PROCEDURES, BY REGION, 2022–2030 (USD MILLION) 127
TABLE 66 JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 129
TABLE 67 JOINT REPLACEMENT DEVICES MARKET FOR CEMENTED FIXATION, BY REGION, 2022–2030 (USD MILLION) 130
TABLE 68 JOINT REPLACEMENT DEVICES MARKET FOR CEMENTLESS FIXATION,
BY REGION, 2022–2030 (USD MILLION) 131
TABLE 69 JOINT REPLACEMENT DEVICES MARKET FOR HYBRID FIXATION, BY REGION, 2022–2030 (USD MILLION) 132
TABLE 70 JOINT REPLACEMENT DEVICES MARKET FOR REVERSE HYBRID FIXATION,
BY REGION, 2022–2030 (USD MILLION) 132
TABLE 71 JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,
2022–2030 (USD MILLION) 134
TABLE 72 JOINT REPLACEMENT DEVICES MARKET FOR TRADITIONAL SURGERY,
BY REGION, 2022–2030 (USD MILLION) 135
TABLE 73 JOINT REPLACEMENT DEVICES MARKET FOR MINIMALLY INVASIVE SURGERY,
BY REGION, 2022–2030 (USD MILLION) 136
TABLE 74 JOINT REPLACEMENT DEVICES MARKET FOR COMPUTER-ASSISTED SURGERY,
BY REGION, 2022–2030 (USD MILLION) 137
TABLE 75 JOINT REPLACEMENT DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 139
TABLE 76 JOINT REPLACEMENT DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022–2030 (USD MILLION) 140
TABLE 77 JOINT REPLACEMENT DEVICES MARKET FOR AMBULATORY CARE CENTERS & TRAUMA UNITS, BY REGION, 2022–2030 (USD MILLION) 141
TABLE 78 JOINT REPLACEMENT DEVICES MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2022–2030 (USD MILLION) 142
TABLE 79 JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 144
TABLE 80 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 146
TABLE 81 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 146
TABLE 82 NORTH AMERICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 147
TABLE 83 NORTH AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 147
TABLE 84 NORTH AMERICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 148
TABLE 85 NORTH AMERICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 148
TABLE 86 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022–2030 (USD MILLION) 149
TABLE 87 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 149
TABLE 88 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,
2022–2030 (USD MILLION) 150
TABLE 89 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 150
TABLE 90 NORTH AMERICA: KEY MACROINDICATORS 151
TABLE 91 US: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 152
TABLE 92 US: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 152
TABLE 93 US: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 153
TABLE 94 US: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 153
TABLE 95 US: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 154
TABLE 96 CANADA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 155
TABLE 97 CANADA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 155
TABLE 98 CANADA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 156
TABLE 99 CANADA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 156
TABLE 100 CANADA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 157
TABLE 101 EUROPE: KEY MACROINDICATORS 158
TABLE 102 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 158
TABLE 103 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 159
TABLE 104 EUROPE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 159
TABLE 105 EUROPE: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 160
TABLE 106 EUROPE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 160
TABLE 107 EUROPE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 161
TABLE 108 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,
2022–2030 (USD MILLION) 161
TABLE 109 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 162
TABLE 110 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,
2022–2030 (USD MILLION) 162
TABLE 111 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 162
TABLE 112 GERMANY: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 163
TABLE 113 GERMANY: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 164
TABLE 114 GERMANY: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 164
TABLE 115 GERMANY: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 165
TABLE 116 GERMANY: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 165
TABLE 117 FRANCE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 166
TABLE 118 FRANCE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 167
TABLE 119 FRANCE: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 167
TABLE 120 FRANCE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 168
TABLE 121 FRANCE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 168
TABLE 122 UK: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 169
TABLE 123 UK: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 169
TABLE 124 UK: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 170
TABLE 125 UK: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 170
TABLE 126 UK: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 171
TABLE 127 ITALY: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 172
TABLE 128 ITALY: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 172
TABLE 129 ITALY: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 173
TABLE 130 ITALY: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 173
TABLE 131 ITALY: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 174
TABLE 132 SPAIN: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 175
TABLE 133 SPAIN: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 175
TABLE 134 SPAIN: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 176
TABLE 135 SPAIN: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 176
TABLE 136 SPAIN: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 177
TABLE 137 REST OF EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 178
TABLE 138 REST OF EUROPE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 178
TABLE 139 REST OF EUROPE: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 179
TABLE 140 REST OF EUROPE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 179
TABLE 141 REST OF EUROPE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 180
TABLE 142 ASIA PACIFIC: KEY MACROINDICATORS 181
TABLE 143 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 183
TABLE 144 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 183
TABLE 145 ASIA PACIFIC: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 184
TABLE 146 ASIA PACIFIC: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2
022–2030 (USD MILLION) 184
TABLE 147 ASIA PACIFIC: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 185
TABLE 148 ASIA PACIFIC: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 185
TABLE 149 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,
2022–2030 (USD MILLION) 186
TABLE 150 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 186
TABLE 151 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,
2022–2030 (USD MILLION) 187
TABLE 152 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 187
TABLE 153 JAPAN: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 188
TABLE 154 JAPAN: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 188
TABLE 155 JAPAN: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 189
TABLE 156 JAPAN: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 189
TABLE 157 JAPAN: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 190
TABLE 158 CHINA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 191
TABLE 159 CHINA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 191
TABLE 160 CHINA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 192
TABLE 161 CHINA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 192
TABLE 162 CHINA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 193
TABLE 163 INDIA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 194
TABLE 164 INDIA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 194
TABLE 165 INDIA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 195
TABLE 166 INDIA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 195
TABLE 167 INDIA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 196
TABLE 168 AUSTRALIA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 197
TABLE 169 AUSTRALIA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 197
TABLE 170 AUSTRALIA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 198
TABLE 171 AUSTRALIA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 198
TABLE 172 AUSTRALIA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 199
TABLE 173 SOUTH KOREA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 200
TABLE 174 SOUTH KOREA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 200
TABLE 175 SOUTH KOREA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 201
TABLE 176 SOUTH KOREA: SHOULDER REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 201
TABLE 177 SOUTH KOREA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 202
TABLE 178 REST OF ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET,
BY PRODUCT, 2022–2030 (USD MILLION) 203
TABLE 179 REST OF ASIA PACIFIC: KNEE REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 203
TABLE 180 REST OF ASIA PACIFIC: HIP REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 204
TABLE 181 REST OF ASIA PACIFIC: SHOULDER REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 204
TABLE 182 REST OF ASIA PACIFIC: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 205
TABLE 183 LATIN AMERICA: KEY MACROINDICATORS 206
TABLE 184 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 206
TABLE 185 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 207
TABLE 186 LATIN AMERICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 207
TABLE 187 LATIN AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 208
TABLE 188 LATIN AMERICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 208
TABLE 189 LATIN AMERICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 209
TABLE 190 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022–2030 (USD MILLION) 209
TABLE 191 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 210
TABLE 192 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,
2022–2030 (USD MILLION) 210
TABLE 193 LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 210
TABLE 194 BRAZIL: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 211
TABLE 195 BRAZIL: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 212
TABLE 196 BRAZIL: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 212
TABLE 197 BRAZIL: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 213
TABLE 198 BRAZIL: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 213
TABLE 199 MEXICO: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 214
TABLE 200 MEXICO: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 214
TABLE 201 MEXICO: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 215
TABLE 202 MEXICO: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 215
TABLE 203 MEXICO: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 216
TABLE 204 REST OF LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 217
TABLE 205 REST OF LATIN AMERICA: KNEE REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 217
TABLE 206 REST OF LATIN AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 218
TABLE 207 REST OF LATIN AMERICA: SHOULDER REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 218
TABLE 208 REST OF LATIN AMERICA: ANKLE REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 219
TABLE 209 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 220
TABLE 210 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 220
TABLE 211 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 221
TABLE 212 MIDDLE EAST & AFRICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 221
TABLE 213 MIDDLE EAST & AFRICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 222
TABLE 214 MIDDLE EAST & AFRICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 222
TABLE 215 MIDDLE EAST & AFRICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 223
TABLE 216 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022–2030 (USD MILLION) 223
TABLE 217 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 224
TABLE 218 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION) 224
TABLE 219 MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET,
BY END USER, 2022–2030 (USD MILLION) 225
TABLE 220 GCC COUNTRIES: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 226
TABLE 221 GCC COUNTRIES: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 226
TABLE 222 GCC COUNTRIES: HIP REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 227
TABLE 223 GCC COUNTRIES: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 227
TABLE 224 GCC COUNTRIES: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 228
TABLE 225 REST OF MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET,
BY PRODUCT, 2022–2030 (USD MILLION) 229
TABLE 226 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 229
TABLE 227 REST OF MIDDLE EAST & AFRICA: HIP REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 230
TABLE 228 REST OF MIDDLE EAST & AFRICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 230
TABLE 229 REST OF MIDDLE EAST & AFRICA: ANKLE REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 231
TABLE 230 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET, 2021−2024 233
TABLE 231 JOINT REPLACEMENT DEVICES MARKET: DEGREE OF COMPETITION 236
TABLE 232 JOINT REPLACEMENT DEVICES MARKET: REGION FOOTPRINT 243
TABLE 233 JOINT REPLACEMENT DEVICES MARKET: PRODUCT TYPE FOOTPRINT 244
TABLE 234 JOINT REPLACEMENT DEVICES MARKET: SURGERY TYPE FOOTPRINT 245
TABLE 235 JOINT REPLACEMENT DEVICES MARKET: TYPE FOOTPRINT 246
TABLE 236 JOINT REPLACEMENT DEVICES MARKET: TECHNIQUE FOOTPRINT 247
TABLE 237 JOINT REPLACEMENT DEVICES MARKET: END-USER FOOTPRINT 248
TABLE 238 JOINT REPLACEMENT DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SMES 251
TABLE 239 JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES (1/4) 252
TABLE 240 JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING O
F KEY STARTUPS/SMES (2/4) 253
TABLE 241 JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES (3/4) 254
TABLE 242 JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES (4/4) 255
TABLE 243 JOINT REPLACEMENT DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024 256
TABLE 244 JOINT REPLACEMENT DEVICES MARKET: DEALS,
JANUARY 2021–DECEMBER 2024 259
TABLE 245 JOINT REPLACEMENT DEVICES MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024 260
TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW 261
TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED 262
TABLE 248 ZIMMER BIOMET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−DECEMBER 2024 265
TABLE 249 ZIMMER BIOMET: DEALS, JANUARY 2021−DECEMBER 2024 266
TABLE 250 STRYKER: COMPANY OVERVIEW 268
TABLE 251 STRYKER: PRODUCTS OFFERED 269
TABLE 252 STRYKER: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021−DECEMBER 2024 273
TABLE 253 STRYKER: DEALS, JANUARY 2021− DECEMBER 2024 273
TABLE 254 STRYKER: EXPANSIONS, JANUARY 2021− DECEMBER 2024 274
TABLE 255 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW 275
TABLE 256 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED 276
TABLE 257 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−DECEMBER 2024 278
TABLE 258 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2021−DECEMBER 2024 279
TABLE 259 SMITH+NEPHEW: COMPANY OVERVIEW 280
TABLE 260 SMITH+NEPHEW: PRODUCTS OFFERED 282
TABLE 261 SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021− DECEMBER 2024 283
TABLE 262 SMITH+NEPHEW: DEALS, JANUARY 2021−DECEMBER 2024 284
TABLE 263 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021−DECEMBER 2024 285
TABLE 264 B. BRAUN: COMPANY OVERVIEW 286
TABLE 265 B. BRAUN: PRODUCTS OFFERED 288
TABLE 266 GLOBUS MEDICAL: COMPANY OVERVIEW 290
TABLE 267 GLOBUS MEDICAL: PRODUCTS OFFERED 292
TABLE 268 GLOBUS MEDICAL: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−DECEMBER 2024 293
TABLE 269 GLOBUS MEDICAL: DEALS, JANUARY 2021−DECEMBER 2024 294
TABLE 270 ARTHREX, INC.: COMPANY OVERVIEW 295
TABLE 271 ARTHREX, INC.: PRODUCTS OFFERED 295
TABLE 272 ENOVIS: COMPANY OVERVIEW 301
TABLE 273 ENOVIS: PRODUCTS OFFERED 302
TABLE 274 ENOVIS: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021−DECEMBER 2024 304
TABLE 275 ENOVIS: DEALS, JANUARY 2021−DECEMBER 2024 305
TABLE 276 ENOVIS: EXPANSIONS, JANUARY 2021−DECEMBER 2024 306
TABLE 277 ACUMED LLC: COMPANY OVERVIEW 307
TABLE 278 ACUMED LLC: PRODUCTS OFFERED 307
TABLE 279 ACUMED LLC: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021−DECEMBER 2024 309
TABLE 280 ACUMED: DEALS, JANUARY 2021− DECEMBER 2024 310
TABLE 281 ACUMED: EXPANSIONS, JANUARY 2021−DECEMBER 2024 310
TABLE 282 ORTHOFIX MEDICAL INC.: COMPANY OVERVIEW 311
TABLE 283 ORTHOFIX MEDICAL INC.: PRODUCTS OFFERED 312
TABLE 284 ORTHOFIX MEDICAL INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021− DECEMBER 2024 314
TABLE 285 ORTHOFIX MEDICAL INC.: DEALS, JANUARY 2021−DECEMBER 2024 315
TABLE 286 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 316
TABLE 287 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 318
TABLE 288 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− DECEMBER 2024 319
TABLE 289 MICROPORT SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−DECEMBER 2024 319
TABLE 290 CONMED CORPORATION: COMPANY OVERVIEW 320
TABLE 291 CONMED CORPORATION: PRODUCTS OFFERED 321
TABLE 292 CONMED CORPORATION: DEALS, JANUARY 2021−DECEMBER 2024 323
TABLE 293 MEDACTA INTERNATIONAL: COMPANY OVERVIEW 324
TABLE 294 MEDACTA INTERNATIONAL: PRODUCTS OFFERED 326
TABLE 295 MEDACTA INTERNATIONAL: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021− DECEMBER 2024 327
TABLE 296 MEDACTA INTERNATIONAL: DEALS, JANUARY 2021−DECEMBER 2024 327
TABLE 297 MEDACTA INTERNATIONAL: EXPANSIONS, JANUARY 2021−DECEMBER 2024 327
TABLE 298 PARAGON 28, INC.: COMPANY OVERVIEW 328
TABLE 299 PARAGON 28, INC.: PRODUCTS OFFERED 329
TABLE 300 PARAGON 28, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− DECEMBER 2024 331
TABLE 301 PARAGON 28, INC.: DEALS, JANUARY 2021− DECEMBER 2024 332
TABLE 302 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 333
TABLE 303 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED 333
TABLE 304 MERIL LIFE SCIENCES PVT. LTD.: EXPANSIONS, JANUARY 2021− DECEMBER 2024 335
TABLE 305 GPC MEDICAL LTD.: COMPANY OVERVIEW 336
TABLE 306 GPC MEDICAL LTD.: PRODUCTS OFFERED 336
TABLE 307 MAXX ORTHOPEDICS, INC.: COMPANY OVERVIEW 337
TABLE 308 MAXX ORTHOPEDICS, INC.: PRODUCTS OFFERED 337
TABLE 309 MAXX ORTHOPEDICS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− DECEMBER 2024 338
TABLE 310 MAXX ORTHOPEDICS, INC.: DEALS, JANUARY 2021−DECEMBER 2024 338
TABLE 311 AUXEIN: COMPANY OVERVIEW 339
TABLE 312 AUXEIN: PRODUCTS OFFERED 339
TABLE 313 AUXEIN: DEALS, JANUARY 2021−DECEMBER 2024 339
TABLE 314 NORAKER: COMPANY OVERVIEW 340
TABLE 315 NORAKER: PRODUCTS OFFERED 340
TABLE 316 NORAKER: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021−DECEMBER 2024 340
TABLE 317 NORAKER: DEALS, JANUARY 2021−DECEMBER 2024 341
TABLE 318 NEXTSTEP ARTHROPEDIX: COMPANY OVERVIEW 342
TABLE 319 NEXTSTEP ARTHROPEDIX: PRODUCTS OFFERED 342
TABLE 320 EXACTECH, INC.: COMPANY OVERVIEW 343
TABLE 321 EXACTECH, INC.: PRODUCTS OFFERED 343
TABLE 322 EXACTECH, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021− DECEMBER 2024 344
TABLE 323 EXACTECH, INC.: DEALS, JANUARY 2021−DECEMBER 2024 345
TABLE 324 FH ORTHO: COMPANY OVERVIEW 346
TABLE 325 SYMBIOS ORTHOPÉDIE S.A.: COMPANY OVERVIEW 347
TABLE 326 MADISON ORTHO: COMPANY OVERVIEW 348
TABLE 327 GREEN SURGICALS PVT. LTD.: COMPANY OVERVIEW 350
TABLE 328 SIORA SURGICAL PVT. LTD.: COMPANY OVERVIEW 355
TABLE 329 ORTHOPEDIATRICS CORP.: COMPANY OVERVIEW 359
TABLE 330 RESTOR3D: COMPANY OVERVIEW 360
TABLE 331 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW 361
TABLE 332 TREACE MEDICAL CONCEPTS, INC.: COMPANY OVERVIEW 365
TABLE 333 AK MEDICAL: COMPANY OVERVIEW 366
_
FIGURE 1 JOINT REPLACEMENT DEVICES MARKET SEGMENTATION
AND GEOGRAPHICAL SPREAD 31
FIGURE 2 JOINT REPLACEMENT DEVICES MARKET: YEARS CONSIDERED 33
FIGURE 3 JOINT REPLACEMENT DEVICES MARKET: RESEARCH DESIGN 34
FIGURE 4 JOINT REPLACEMENT DEVICES MARKET: KEY PRIMARY SOURCES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS) 36
FIGURE 5 JOINT REPLACEMENT DEVICES: KEY INSIGHTS FROM PRIMARIES 37
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 37
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 38
FIGURE 8 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 39
FIGURE 9 JOINT REPLACEMENT DEVICES MARKET: COMPANY REVENUE ESTIMATION 40
FIGURE 10 JOINT REPLACEMENT DEVICES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 41
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
FIGURE 12 JOINT REPLACEMENT DEVICES MARKET: DATA TRIANGULATION 43
FIGURE 13 JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,
2024 VS. 2030 (USD MILLION) 46
FIGURE 14 JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,
2024 VS. 2030 (USD MILLION) 47
FIGURE 15 JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION) 47
FIGURE 16 JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,
2024 VS. 2030 (USD MILLION) 48
FIGURE 17 JOINT REPLACEMENT DEVICES MARKET, BY END USER,
2024 VS. 2030 (USD MILLION) 49
FIGURE 18 GEOGRAPHIC SNAPSHOT OF JOINT REPLACEMENT DEVICES MARKET 50
FIGURE 19 INCREASING GERIATRIC POPULATION AND RISING RESEARCH
FUNDING TO DRIVE MARKET 51
FIGURE 20 HIP REPLACEMENT DEVICES TO COMMAND LARGEST
MARKET SHARE DURING STUDY PERIOD 52
FIGURE 21 TOTAL REPLACEMENT PROCEDURES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD 53
FIGURE 22 HOSPITALS & SURGICAL CENTERS TO COMMAND LARGEST MARKET SHARE FROM 2024 TO 2030 54
FIGURE 23 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 55
FIGURE 24 JOINT REPLACEMENT DEVICES MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 56
FIGURE 25 JOINT REPLACEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 26 JOINT REPLACEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS 65
FIGURE 27 JOINT REPLACEMENT DEVICES MARKET: ECOSYSTEM ANALYSIS 66
FIGURE 28 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 71
FIGURE 29 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 73
FIGURE 30 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 75
FIGURE 31 INVESTMENT AND FUNDING SCENARIO, 2019−2023 82
FIGURE 32 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019−2023 83
FIGURE 33 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION) 83
FIGURE 34 AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES,
BY PRODUCT, 2023 (USD) 84
FIGURE 35 AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES,
BY REGION, 2023 (USD) 85
FIGURE 36 PATENT ANALYSIS FOR JOINT REPLACEMENT DEVICES MARKET (JANUARY 2014–SEPTEMBER 2024) 89
FIGURE 37 JOINT REPLACEMENT DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 91
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF J
OINT REPLACEMENT DEVICES 93
FIGURE 39 KEY BUYING CRITERIA, BY END USER 94
FIGURE 40 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 99
FIGURE 41 MARKET POTENTIAL OF AI IN JOINT REPLACEMENT DEVICES MARKET 101
FIGURE 42 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET SNAPSHOT 145
FIGURE 43 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET SNAPSHOT 182
FIGURE 44 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET, 2019−2023 235
FIGURE 45 JOINT REPLACEMENT DEVICES MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023 236
FIGURE 46 EV/EBITDA OF KEY VENDORS, 2024 237
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024 238
FIGURE 48 JOINT REPLACEMENT DEVICES MARKET: BRAND/PRODUCT COMPARISON 239
FIGURE 49 JOINT REPLACEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 241
FIGURE 50 JOINT REPLACEMENT DEVICES MARKET: COMPANY FOOTPRINT 242
FIGURE 51 JOINT REPLACEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 250
FIGURE 52 ZIMMER BIOMET: COMPANY SNAPSHOT (2023) 262
FIGURE 53 STRYKER: COMPANY SNAPSHOT (2023) 269
FIGURE 54 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023) 276
FIGURE 55 SMITH+NEPHEW: COMPANY SNAPSHOT (2023) 281
FIGURE 56 B. BRAUN: COMPANY SNAPSHOT (2023) 287
FIGURE 57 GLOBUS MEDICAL: COMPANY SNAPSHOT (2023) 291
FIGURE 58 ENOVIS: COMPANY SNAPSHOT (2023) 302
FIGURE 59 ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT (2023) 312
FIGURE 60 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 317
FIGURE 61 CONMED CORPORATION: COMPANY SNAPSHOT (2023) 321
FIGURE 62 MEDACTA INTERNATIONAL: COMPANY SNAPSHOT (2023) 325
FIGURE 63 PARAGON 28, INC.: COMPANY SNAPSHOT (2023) 329